サインイン

Jodie Hay

Paul O'Gorman Leukaemia Research Centre,
Institute of Cancer Sciences,
College of Medical,
Veterinary and Life Sciences,
Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences

University of Glasgow

BIOGRAPHY

Jodie Hay is a Research Associate at the Paul O'Gorman Leukaemia Research Centre part of the University of Glasgow. She received her undergraduate with honours degree in Forensic Science with Chemistry from The Robert Gordon University, Aberdeen, and a Ph.D. in Medicine from the Queen's University Belfast.

During Dr Hay's training she has worked on a number of haematological malignancies including AML, T-ALL and B cell lymphoma. She joined the Michie group in 2018 as a senior postdoctoral research scientist to explore the cellular and molecular mechanisms that underlie the initiation and progression of chronic lymphocytic leukaemia (CLL), with a view to identifying novel targets for therapeutic intervention.

PUBLICATIONS

Addiction to Runx1 is partially attenuated by loss of p53 in the Eµ-Myc lymphoma model.

Oncotarget Apr, 2016 | Pubmed ID: 27056890

The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models.

Advances in experimental medicine and biology , 2017 | Pubmed ID: 28299662

RUNX oncoproteins and miRNA networks.

Oncotarget Sep, 2017 | Pubmed ID: 28968950

Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy.

Oncotarget Sep, 2017 | Pubmed ID: 28978082

RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins.

Journal of cellular biochemistry 03, 2018 | Pubmed ID: 29052866

AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival.

Clinical cancer research : an official journal of the American Association for Cancer Research Mar, 2019 | Pubmed ID: 30559170

Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activity.

Journal of cellular biochemistry Oct, 2019 | Pubmed ID: 31257681

INSTITUTIONS

University of Glasgow

JOVE ARTICLES

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Jodie Hay^*,1,

Michael W. Moles^*,1,

Jennifer Cassels¹,

Alison M. Michie¹

¹Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow

JoVE Journal

個人情報保護方針

利用規約

一般データ保護規則

お問い合わせ

図書館への推薦

JoVE ニュースレター

研究

JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
教員用サイト

著者

概要
出版プロセス
編集委員会
スコープと指針
査読
よくある質問
お申し込み

図書館員

概要
お客様の声
定期購読
アクセス
リソース
図書館諮問委員会
よくある質問

JoVEについて

概要
経営陣
ブログ
JoVE Help Center